Health Minister Mohamed Mchengerwa has officially laid the foundation stone for the Mloganzila Pharmaceutical...
1,405 acres of investment-ready pharmaceutical and medical device infrastructure serving East and Southern Africa.
TZ pharma market, today
Projected growth (15Y)
MSD procurement / yr
Acres across two sites
EAC + SADC reach
TMDA fast-track
Tanzania’s pharma market is already worth over a billion US dollars a year— and projected to grow 4.6× over the next 15 years as UHI scales from 8% to 85% coverage. Demand is structural, contracted, and locked in.
MSD buys USD 491M of medicines and devices a year via 5–7 year framework agreements, with 15% local-preference written into procurement law
One Tanzanian production line
serves the East African Community and SADC — 780 million consumers — through abridged-review and mutual-recognition pathways.
TMDA is one of only four WHO
Maturity-Level-3 regulators in Africa. PIAT’s Green-Lane gives investors one inter-agency contact, not five waiting rooms.
405 acres at Mloganzila next to East Africa’s largest teaching hospital. 1,000 acres at Bagamoyo on the deep-water corridor. Plot allocation in 60 days, not 18 months.
Two mandates. One zone.
A complete manufacturing value chain.
MPMED-SEZ is the only Special Economic Zone in East Africa integrating pharmaceutical manufacturing and medical device assembly within a single, formally designated industrial zone — serving a domestic public procurement market worth USD 491 million annually (MSD) with import dependency exceeding 80%, while providing access to over 331 million consumers across the EAC and more than 450 million across SADC.
Tanzania imports more than 80% of its medicines — with only 19 local pharmaceutical manufacturing facilities compared to 726 approved foreign manufacturers supplying the market. MPMED-SEZ is the designated zone to scale domestic production of generics, biologics, APIs, vaccines, and traditional medicines at industrial scale under WHO-GMP compliant manufacturing standards.
More than 90% of Tanzania’s medical devices and 99% of diagnostic equipment are imported — with 157,444 import permits issued between 2022–2025 alone. MPMED-SEZ establishes East Africa’s first dedicated medical device assembly zone — supporting precision surgical instruments, clinical consumables, IVD diagnostics, and digital health technologies.
Explore 1,405 acres of dedicated pharmaceutical manufacturing land across Tanzania’s two strategic investment zones.
Dar es Salaam Region
Coastal Export Corridor
MPMED-SEZ is designed to establish a world-class pharmaceutical and medical device manufacturing ecosystem that strengthens healthcare security, attracts strategic investment, and positions Tanzania as a leading regional production hub.
Through dedicated industrial zones, investment incentives, and coordinated government support, MPMED-SEZ creates a platform for sustainable industrial growth and regional market access.
Develop a globally competitive pharmaceutical and medical device manufacturing ecosystem with modern infrastructure and investment-ready industrial zones.
Reduce barriers through fiscal incentives, streamlined approvals, regulatory support, and coordinated investor services.
Leverage government procurement programs and local preference policies to support sustainable market demand for local manufacturers.
Enable access to East African and Southern African markets, creating opportunities to serve more than 780 million consumers.
Get the latest investment news, regulatory developments, project milestones, and strategic announcements shaping the future of pharmaceutical manufacturing.
Health Minister Mohamed Mchengerwa has officially laid the foundation stone for the Mloganzila Pharmaceutical...
Health Minister Mohamed Mchengerwa has announced a definitive, high-level strategic shift aimed at rapidly...
President Samia Suluhu Hassan has issued an immediate executive mandate targeting the rapid expansion...
DAR ES SALAAM – In a decisive move to strengthen national health security and...
Join the next generation of pharmaceutical manufacturers shaping Africa’s healthcare future.